Cannabis ein sicherer mid-bigcap- Hafen?
Optionen
| Boardmail an "bozkurt7" |
Wertpapier: Auxly Cannabis Group In |
https://nesta.co
Dann werden bei Facebook gerade Fragen für ein Meeting mit dem Vorstand gesammelt (bisher über 50 ziemlich interessante Fragen).
Die ersten Filialen haben eröffnet.
Leute habt Geduld.
Das waren die bescheidenen Q4/2018 Zahlen.
Das Q1/2019 wird deutlich besser.
Warum der Kurs nicht abhebt, liegt daran, dass der ganze Sektor gerade schwächelt.
Die Shorts haben sich gerade auf Aurora eingeschossen und deckeln damit den ganzen Sektor.
Wenn es zu keiner Kapitalmaßnahme mehr kommt, sehen wir bald Kurse mit einer 1 vor dem Komma.
Aber bis 2020 würde ich halten, wenn sich das ganze für euch lohnen soll...
Angehängte Grafik:
screenshot_at_apr_02_19-44-38.jpg (verkleinert auf 51%)
screenshot_at_apr_02_19-44-38.jpg (verkleinert auf 51%)
A few key notes from the MD&A - Maybe it can be of use to somebody.
In January 2019, we received our first shipments of cannabis from several partners with delivery and production expected to increase steadily throughout the year. (3)
We are also focused on additional opportunities in the LATAM region, Europe, and North America through strategic partnerships, joint ventures and supply arrangements including leveraging our existing relationships with Inverell, Aphria Inc. (“Aphria”), and ICC International Cannabis Corp. (3)
Kolab commenced sales of medical cannabis products in February 2019. (4)
On February 22, 2019, $8,895 was received to fully settle the Sundial promissory note. (6)
In the first quarter of 2019, the Company received approximately $4,280 back [from Dixie] due to mainly regulatory milestone events. (7)
Dosecann and Delta 9 are currently negotiating a supply agreement for the creation and supply of certain value-added cannabis products from Dosecann. (9)
On January 8, 2019, the Company and Green Relief Inc. (“Green Relief”) mutually terminated their interim agreement. As consideration for the termination, the Company received 496,689 common shares of Green Relief, representing approximately 0.5% of Green Relief on a nondiluted basis; and entered into a cannabis sales framework agreement pursuant to which the Company is entitled to purchase up to 3,000,000 grams of dried cannabis from Green Relief at a purchase price of $1.50 per gram (subject to CPI adjustment) over a three year period commencing no later than Q3 2019. (10)
On January 2, 2019, the Company commenced a confidential arbitration under the Vivo Agreements, which process is ongoing. (10)
As Auxly, prepares for cannabis sales beyond 2018, expenses have increased since Q2 2017 due to the build out of the business through acquisitions (employees, professional fees), additional employees in the corporate offices and share compensation expenses. (14)
Auxly anticipates that it has liquidity and capital resources to meet short term obligations, however, will require additional funding to complete all projects and meet all commitments contemplated in 2019. (18)
Auxly believes it will have sufficient capital for the next 12 months upon successful completion of contemplated financing activities. (18)
Mal ne gute Meldung vom Unternehmen wäre auch nicht schlecht.
Am 30.5. gibt es hier die nächsten Zahlen. Und das Q1/2019 ist verglichen mit den letzten Zahlen ein großer Schritt nach vorn. Danach müsste noch ein starker Partner gefunden werden, dann geht die Rakete an den anderen Cannabis-Werten vorbei nach oben.
Also... Geduld und Vertrauen in Chuck. Und nicht verunsichern lassen, es wird viel durch News manipuliert. Trader wollen auch von was leben. Ich bleibe investiert und zuversichtlich.
https://www.arte.tv/de/videos/080157-000-A/...er-grosse-hype-um-hanf/
https://www.instagram.com/p/Bwr2Kd_hLja/?utm_source=ig_share_sheet